105 related articles for article (PubMed ID: 7149653)
1. Metastatic retinoblastoma and L-phenylalanine mustard-dianhydrogalactitol.
Helson L; Kitchin FD; Abramson D; Ellsworth RM
Anticancer Res; 1982; 2(4):235-8. PubMed ID: 7149653
[TBL] [Abstract][Full Text] [Related]
2. Human meningeal sarcoma heterotransplants in Nu/Nu mice treated with L-phenylalanine mustard (L-PAM) and dianhydrogalactitol (DAG).
Member B; Helson L; Helson C; Erlandson R; Hajdu SI
Anticancer Res; 1985; 5(5):559-64. PubMed ID: 3840666
[TBL] [Abstract][Full Text] [Related]
3. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
[No Abstract] [Full Text] [Related]
4. [Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy].
Fan YJ; Zhou J; Li M
Yao Xue Xue Bao; 1983 Sep; 18(9):648-53. PubMed ID: 6677049
[No Abstract] [Full Text] [Related]
5. Responsiveness of retinoblastoma to local diaziquone. Studies in a xenograft model.
White L
Invest Ophthalmol Vis Sci; 1990 May; 31(5):787-91. PubMed ID: 2335447
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):517-9. PubMed ID: 7195306
[No Abstract] [Full Text] [Related]
7. Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.
Helson L; Rozsa P; Hajdu E; Helson JL
Cancer Treat Rep; 1980; 64(12):1287-94. PubMed ID: 7471118
[TBL] [Abstract][Full Text] [Related]
8. Tissue concentrations of doxorubicin in animal models with engrafted intraocular tumours.
White L; Chan KK; Barrientos A; Gomer CJ; Murpheree AL; Benedict WF
In Vivo; 1989; 3(5):315-7. PubMed ID: 2519871
[TBL] [Abstract][Full Text] [Related]
9. Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases.
Creagan ET; Eagan RT; Rubin J
Med Pediatr Oncol; 1979; 7(2):179-80. PubMed ID: 502975
[No Abstract] [Full Text] [Related]
10. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
11. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.
Howard MA; Wardwell S; Albert DM
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1711-3. PubMed ID: 2032794
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
13. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement.
Matsubara H; Makimoto A; Higa T; Kawamoto H; Sakiyama S; Hosono A; Takayama J; Takaue Y; Murayama S; Sumi M; Kaneko A; Ohira M
Bone Marrow Transplant; 2005 Apr; 35(8):763-6. PubMed ID: 15750608
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma.
Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W
Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463
[TBL] [Abstract][Full Text] [Related]
15. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Creagan ET; Eagan RT; Kvols LK
Oncology; 1981; 38(5):260-1. PubMed ID: 7196561
[TBL] [Abstract][Full Text] [Related]
16. [Drug formulation of a cytostatic compound and testing of the parenteral preparation].
Stampf G; Kaszáné TE; Czirják F; Dávid A
Acta Pharm Hung; 1982 Sep; 52(5):193-9. PubMed ID: 7148474
[No Abstract] [Full Text] [Related]
17. Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Taçyildiz N; Yavuz G; Unal E; Gündüz K; Günalp I; Ekinci C
Pediatr Hematol Oncol; 2003 Sep; 20(6):473-6. PubMed ID: 14631622
[TBL] [Abstract][Full Text] [Related]
18. [Does chemotherapy have a role in the treatment of retinoblastomas?].
Campinchi R; Lemerle J; Bloch-Michel E; Pinget T; Schweisguth O; Luker P; Schlienger E; Chassagne A; Barret F
Bull Soc Ophtalmol Fr; 1976 Jan; 76(1):17-22. PubMed ID: 1000747
[No Abstract] [Full Text] [Related]
19. Treatment of metastatic retinoblastoma.
Rodriguez-Galindo C; Wilson MW; Haik BG; Lipson MJ; Cain A; Merchant TE; Kaste S; Pratt CB
Ophthalmology; 2003 Jun; 110(6):1237-40. PubMed ID: 12799253
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
Ji X; Cheng L; Wei F; Li H; Wang M; Tian Y; Chen X; Wang Y; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5544-51. PubMed ID: 19608529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
